AskTheDate.com
Back to calendar

Tarsus Pharmaceuticals, Inc. (TARS) Earnings

TARS reports earnings on Thursday, August 6, 2026

earnings report
August 6, 2026
Q2 2026
Est. EPS: $-1.55
Actual EPS: $-0.43
EPS surprise: -124.22%
Company overview
Market Cap$3.1B
PriceUSD 70.05
EPS (TTM)-1.08
52-week high85.25
52-week low48.20
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees370